Tatva Chintan Pharma Chem Limited (TATVA) - Total Liabilities

Latest as of September 2025: Rs1.53 Billion INR ≈ $16.58 Million USD

Based on the latest financial reports, Tatva Chintan Pharma Chem Limited (TATVA) has total liabilities worth Rs1.53 Billion INR (≈ $16.58 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check TATVA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Tatva Chintan Pharma Chem Limited - Total Liabilities Trend (2018–2025)

This chart illustrates how Tatva Chintan Pharma Chem Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Tatva Chintan Pharma Chem Limited.

Tatva Chintan Pharma Chem Limited Competitors by Total Liabilities

The table below lists competitors of Tatva Chintan Pharma Chem Limited ranked by their total liabilities.

Company Country Total Liabilities
HelloFresh SE
XETRA:HFG
Germany €1.58 Billion
Guangdong Fangyuan Environment Co. Ltd. A
SHG:688148
China CN¥2.43 Billion
Lafang China
SHG:603630
China CN¥257.81 Million
Yibin Paper Industry Co Ltd
SHG:600793
China CN¥2.93 Billion
PetroVietnam Transportation Corp
VN:PVT
Vietnam ₫10.84 Trillion
BlackRock Energy and Resources Closed Fund
NYSE:BGR
USA $1.72 Million
Marimekko Oyj
HE:MEKKO
Finland €50.40 Million
Daewoong
KO:003090
Korea ₩1.60 Trillion

Liability Composition Analysis (2018–2025)

This chart breaks down Tatva Chintan Pharma Chem Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See TATVA equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tatva Chintan Pharma Chem Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tatva Chintan Pharma Chem Limited (2018–2025)

The table below shows the annual total liabilities of Tatva Chintan Pharma Chem Limited from 2018 to 2025.

Year Total Liabilities Change
2025-03-31 Rs974.25 Million
≈ $10.54 Million
+19.34%
2024-03-31 Rs816.36 Million
≈ $8.83 Million
-66.20%
2023-03-31 Rs2.42 Billion
≈ $26.12 Million
+30.40%
2022-03-31 Rs1.85 Billion
≈ $20.03 Million
+24.44%
2021-03-31 Rs1.49 Billion
≈ $16.10 Million
+13.41%
2020-03-31 Rs1.31 Billion
≈ $14.19 Million
+21.74%
2019-03-31 Rs1.08 Billion
≈ $11.66 Million
+26.46%
2018-03-31 Rs852.48 Million
≈ $9.22 Million
--

About Tatva Chintan Pharma Chem Limited

NSE:TATVA India Specialty Chemicals
Market Cap
$447.82 Million
Rs41.41 Billion INR
Market Cap Rank
#12936 Global
#645 in India
Share Price
Rs1770.20
Change (1 day)
+3.54%
52-Week Range
Rs991.50 - Rs1800.10
All Time High
Rs2866.25
About

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more